Condensed Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Net cash used in operating activities	$ (260,320)	$ (474,912)
Cash from investing activities:
Patent expenditures	(7,832)	(14,079)
Net cash used in investing activities	(7,832)	(14,079)
Cash from financing activities:
Proceeds from issuance of note payable related party	261,892	573,835
Payments on notes payable related party		(82,500)
Purchase and cancellation of treasury stock		(500)
Net cash provided by financing activities	261,892	490,835
Net change in cash	(6,260)	1,844
Cash and cash equivalents at beginning of period	6,539	7,261
Cash and cash equivalents at end of period	279	9,105
Supplemental disclosure of cash flow information
Cash paid for interest	1,320	3,669
Cash paid for income taxes	$ 0	$ 0